1. Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer
   Anthony Ambesi et al, 2022, Cells CrossRef
2. Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients
   Maha E. Houssen et al, 2024, Pneumonia CrossRef
3. Toll-Like Receptors: General Molecular and Structural Biology
   Payam Behzadi et al, 2021, Journal of Immunology Research CrossRef
4. A Breast Cancer Prediction Model Based on a Panel from Circulating Exosomal miRNAs
   Yangyang Pan et al, 2022, BioMed Research International CrossRef
5. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
   Frank Fang Yao Lee et al, 2022, Frontiers in Immunology CrossRef
6. Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients
   Inas Moaz et al, 2023, Cancer Control CrossRef
7. Age- and Sex- Dependent Changes in Serum Levels of TAS, TOS, TLR2, TLR4, HSP60, HSP90, and HMGB1
   Salih Tunç KAYA, 2023, Konuralp Tıp Dergisi CrossRef
8. Toll‐like receptors in health and disease
   Kunyu Wang et al, 2024, MedComm CrossRef